Dr Jennifer Rosenthal Appointed Director of Quality and Regulatory Affairs
Sydney, Australia 23 October 2019 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the appointment of Dr Jennifer Rosenthal as Director of Quality and Regulatory Affairs. Jennifer has more than 20 years’ management experience in the biotechnology industry, serving in senior director and executive level roles…